Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Gene Therapy Targeting PCSK9
PCSK9 Inhibitors
PCSK9 and the nervous system: a no-brainer? - Journal of Lipid Research
Naturally Occurring PCSK9 Inhibitors
PCSK9 | Circulation Research
Pancreatic PCSK9 controls the organization of the β-cell secretory ...
Cholesterol & the PCSK9 Pathway
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future ...
Frontiers | Proteomics and Lipidomics to unveil the contribution of ...
PCSK9 inhibitors – mechanisms of action - Australian Prescriber
What is PCSK9 and the role of PCSK9 inhibitors
(PDF) Naturally occurring PCSK9 inhibitors
Cholesterol-lowering Star – PCSK9 Inhibitors
PCSK9 and its Inhibitors: A new approach in lipid lowering therapy ...
pcsk9 inhibitors – レクビオ 作用機序 – YEGAE
Frontiers | Regulation of PCSK9 Expression and Function: Mechanisms and ...
PCSK9 Inhibitors: The Evolving Future - Jeswani - 2024 - Health Science ...
PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic
PCSK9 inhibitors: A new era of lipid lowering therapy - PMC
The Anti-Thrombotic Effects of PCSK9 Inhibitors
Pcsk9 inhibitors thesis defence | PPTX
IJMS | Free Full-Text | PCSK9 as an Atherothrombotic Risk Factor
Mechanism of action of statins and PCSK9 inhibitors. The figure ...
A New Approach to PCSK9 Therapeutics | Circulation Research
New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol ...
Clinical Feature: The PCSK9 Revolution: Hope or Hype? Latest Clinical ...
PCSK9 Inhibitors PP
降脂药物研究利器-B6-hPCSK9小鼠
Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease ...
Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review ...
PCSK9 Inhibitors and Managing Cost in the Managed Care Setting | AJMC
PCSK9 inhibitors
ESC 2018 | 李建军:药物机制是 PCSK9 抑制剂临床获益的有力保证 - 丁香园
Pleiotropic Effects of PCSK9 Inhibitors on Cardio-Cerebrovascular ...
PCSK9 Inhibitors: The Facts At-a-Glance
PCSK9 Inhibitors: Promising Strategies for Cholesterol Management
PCSK9 Inhibitors Market Anticipate to Accelerate in the Coming 10 Years ...
Oral PCSK9 Inhibitors as an Emerging Frontier in Lipid Management: A ...
Effects of PCSK9 inhibitors on platelet function - PMC
Stimulation by CAP1 and inhibition by P1.40 of PCSK9 activity ...
Why Merck's PCSK9 Inhibitors Are a Big Deal
PCSK9 signaling pathways and their potential importance in clinical ...
2017 NLA guidelines: PCSK9 inhibition and cholesterol - GT health
Inhibition of PCSK9: A Promising Enhancer for Anti-PD-1/PD-L1 Immunotherapy
International Journal of Molecular Medicine
Class Sanskrit Grammar Char Dhatu Dhatu Roop, 48% OFF
PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in ...
Inhibitory PCSK9 – WikiSkripta
Figure 1 from Recent Advances on the Roles of PCSK-9 Inhibitors in the ...
Association of Circulating PCSK9 With Ischemia-Reperfusion Injury in ...
Frontiers | PCSK9 Variants in Familial Hypercholesterolemia: A ...
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and ...
PCSK9 Inhibitors: The Evolving Future - PMC
中国首个自主研发的PCSK9抑制剂信必乐®获批上市,用于治疗原发性高胆固醇血症和混合型血脂异常患者
The PCSK9 Inhibitors: A Lipid-lowering Therapy to Treat Atherosclerotic ...
The Evolving Future of PCSK9 Inhibitors | JACC
PCSK9 Inhibitors Video
The mechanism of PCSK9 synthesis inhibition by inclisiran. Inclisiran ...
PCSK9 inhibitors in the prevention of cardiovascular disease - PMC
PCSK9 Activity Is Potentiated Through HDL Binding | Circulation Research
The local effects of proprotein convertase subtilisin/kexin type 9 ...
The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion ...
PCSK9 Inhibitors May Increase Parkinson's Disease & Reduce ALS Risk ...
(PDF) PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current ...
Frontiers | PCSK9 regulates the efficacy of immune checkpoint therapy ...
李建军:药物机制是PCSK9抑制剂临床获益的有力保证-MedSci.cn
PCSK9 Inhibitors Topic Review | Learn the Heart
Practical guide for the use of PCSK9 inhibitors in Portugal | Revista ...
PCSK9 inhibition potentiates cancer immune checkpoint therapy - PMC
Frontiers | Non-antibody Approaches to Proprotein Convertase Subtilisin ...
PCSK9 Αναστολείς | Μικροβιολογικό Λαμία
Frontiers | Editorial: PCSK9: Importance in Physiology and Pathophysiology
Frontiers | Effect of PCSK9 on atherosclerotic cardiovascular diseases ...
PCSK9 Targeting in the Management of Hypercholesterolaemia - European ...
Clinical Trends for April 2016 - Page 3
Pleiotropic Effects of PCSK9 Inhibitors on Cardio-Cerebrovascular Diseases
Targeting PCSK9 reduces cancer cell stemness and enhances antitumor ...
The association between circulatory, local pancreatic PCSK9 and type 2 ...
PCSK9 Inhibitors Treatment, Companies, Market Trends | PCSK9 Inhibitors ...
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid ...
PCSK9 inhibitors are a new class of drugs that lower low-density ...
Metabolites | Free Full-Text | The Emerging Roles of Intracellular ...
PCSK9 Base Editing Therapeutics and Ischemic St...
A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in ...
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage ...
PCSK9: From Nature’s Loss to Patient’s Gain | Circulation
Frontiers | Interactions between PCSK9 and NLRP3 inflammasome signaling ...
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron ...
New opportunities for cholesterol lowering: focus on PCSK9 inhibitors ...
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the ...
Advancements in PCSK9 Inhibitors - BOC Sciences
Merck's Oral PCSK9 Drug Enlicitide Meets Phase 3 Trial Goals | MRK ...
PCSK9 inhibitors and cardiovascular disease: heralding a new ...
Frontiers | A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022
PCSK9抑制剂进医保降价近千元,每月用药2次,能替代他汀吗_李津_副主任药师_爱问健康
Pcsk 9 inhibitors | PPTX
Frontiers | Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in ...
PCSK9 Inhibitors: Pharmacology, Indications, Drug Interactions, Dosing ...
PCSK9 Presentation and Its Inhibition.pdf
Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD ...